Biologics in dermatologic therapy - an update
- PMID: 20161849
- PMCID: PMC2810684
- DOI: 10.4103/0019-5154.55627
Biologics in dermatologic therapy - an update
Abstract
Biologics are protein molecules which are used in various diseases to target the specific points in the immunopathogenesis of the diseases. The molecules are produced by recombinant DNA technology. The molecules bind to the specific targets without interfering wtih rest of the pathogenetic pathways. Therefore the so called 'immunosuppressives' have, although, a broader broader spectrum of action on immune system, their side-effects are also equally more. The biologics, because of their spefic action on the immune system, have very little side effects. The biologics which have revolutionized the treatment of various dermatologic diseases have been discussed here.
Keywords: Biologics; granulocyte macrophage; interferon; interleukin.
Conflict of interest statement
References
-
- Mehlis S, Gordon KB. From laboratory to clinic: Rationale for biologic therapy. Dermatol Clin. 2004;22:371–7. - PubMed
-
- Dogra A, Salonie S. Biologic therapy in psoriasis. Indian J Dermatol Venereol Leprol. 2006;72:256–65. - PubMed
-
- Lebwohl M. A clinician's paradigm in the treatment of Psoriasis. J Am Acad Derm. 2005;53:559–69. - PubMed
-
- Krueger G, Ellis CN. Psoriasis – recent advances in understanding its pathogenesis and treatment. J Am Acad Derm. 2005;53:594–600. - PubMed
-
- Kipnis CD, Myers WA, Opeola M, Gottlieb AB. Biologic treatments for Psoriasis. J Am Acad Dermatol. 2005;52:671–82. - PubMed
LinkOut - more resources
Full Text Sources